Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
NCT00097344Phase 3Terminated
- Sponsor
- Intarcia Therapeutics
- Start
- Dec 2004
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 5
01
Overview
A Phase 3 trial of atamestane in breast cancer, sponsored by Intarcia Therapeutics. Started Dec 2004; status: terminated.
02
Drugs
atamestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00097344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097344.